seed
Stage
1
Investors
About
RevoNA is developing a novel, non-invasive diagnostic platform for the early detection of neurodegenerative diseases, beginning with Alzheimer's. The company utilizes advanced proteomics and machine learning to identify specific biomarkers in blood.
Explore RevoNA's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.